APO Research
Talk to an analyst

APO RESEARCH · REPORT

Endocrine Therapy Drugs (ETDs)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Endocrine Therapy Drugs (ETDs) Industry Growth and Trends Forecast to 2032

2 January 202695 pages

Choose your research edition.

Industry ResearchEndocrine Therapy Drugs (ETDs) Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Endocrine Therapy Drugs (ETDs) Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Endocrine Therapy Drugs (ETDs) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Endocrine Therapy Drugs (ETDs) Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Endocrine Therapy Drugs (ETDs) Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Endocrine Therapy Drugs (ETDs) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Endocrine Therapy Drugs (ETDs) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Endocrine Therapy Drugs (ETDs) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Endocrine Therapy Drugs (ETDs) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Endocrine Therapy Drugs (ETDs) include Sanofi, Pfizer, Bayer, AstraZeneca, Tonghua Dongbao Pharmaceutical, Novo Nordisk, MSD, Huadong Medicine and Generex Biotechnology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Endocrine Therapy Drugs (ETDs) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Endocrine Therapy Drugs (ETDs) market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Endocrine Therapy Drugs (ETDs) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Endocrine Therapy Drugs (ETDs).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Endocrine Therapy Drugs (ETDs) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Endocrine Therapy Drugs (ETDs) Market by Company

Sanofi

Pfizer

Bayer

AstraZeneca

Tonghua Dongbao Pharmaceutical

Novo Nordisk

MSD

Huadong Medicine

Generex Biotechnology

Endocrine Therapy Drugs (ETDs) Segment by Type

Antidiabetic Drugs

Anti-osteoporosis Drugs

Contraceptive

Other

Endocrine Therapy Drugs (ETDs) Segment by Application

Diabetes Treatment

Osteoporosis Treatment

Contraception

Other

Endocrine Therapy Drugs (ETDs) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Endocrine Therapy Drugs (ETDs) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Endocrine Therapy Drugs (ETDs) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Endocrine Therapy Drugs (ETDs).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Endocrine Therapy Drugs (ETDs) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Endocrine Therapy Drugs (ETDs) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Antidiabetic Drugs Table 2. Major Company of Anti-osteoporosis Drugs Table 3. Major Company of Contraceptive Table 4. Major Company of Other Table 5. Global Endocrine Therapy Drugs (ETDs) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Endocrine Therapy Drugs (ETDs) Sales by Type (2021-2026) & (Tons) Table 7. Global Endocrine Therapy Drugs (ETDs) Sales Market Share in Volume by Type (2021-2026) Table 8. Global Endocrine Therapy Drugs (ETDs) Sales by Type (2021-2026) & (US$ Million) Table 9. Global Endocrine Therapy Drugs (ETDs) Sales Market Share in Value by Type (2021-2026) Table 10. Global Endocrine Therapy Drugs (ETDs) Price by Type (2021-2026) & (US$/Ton) Table 11. Global Endocrine Therapy Drugs (ETDs) Sales by Type (2027-2032) & (Tons) Table 12. Global Endocrine Therapy Drugs (ETDs) Sales Market Share in Volume by Type (2027-2032) Table 13. Global Endocrine Therapy Drugs (ETDs) Sales by Type (2027-2032) & (US$ Million) Table 14. Global Endocrine Therapy Drugs (ETDs) Sales Market Share in Value by Type (2027-2032) Table 15. Global Endocrine Therapy Drugs (ETDs) Price by Type (2027-2032) & (US$/Ton) Table 16. North America Endocrine Therapy Drugs (ETDs) Sales by Type (2021-2026) & (Tons) Table 17. North America Endocrine Therapy Drugs (ETDs) Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Endocrine Therapy Drugs (ETDs) Sales by Type (2021-2026) & (Tons) Table 19. Europe Endocrine Therapy Drugs (ETDs) Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Endocrine Therapy Drugs (ETDs) Sales by Type (2021-2026) & (Tons) Table 21. Asia-Pacific Endocrine Therapy Drugs (ETDs) Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Endocrine Therapy Drugs (ETDs) Sales by Type (2021-2026) & (Tons) Table 23. Latin America Endocrine Therapy Drugs (ETDs) Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Endocrine Therapy Drugs (ETDs) Sales by Type (2021-2026) & (Tons) Table 25. Middle East and Africa Endocrine Therapy Drugs (ETDs) Sales by Type (2021-2026) & (US$ Million) Table 26. Endocrine Therapy Drugs (ETDs) Industry Trends Table 27. Endocrine Therapy Drugs (ETDs) Industry Drivers Table 28. Endocrine Therapy Drugs (ETDs) Industry Opportunities and Challenges Table 29. Endocrine Therapy Drugs (ETDs) Industry Restraints Table 30. Global Endocrine Therapy Drugs (ETDs) Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Company (2021-2026) Table 32. Global Endocrine Therapy Drugs (ETDs) Sales by Company (2021-2026) & (Tons) Table 33. Global Endocrine Therapy Drugs (ETDs) Sales Share by Company (2021-2026) Table 34. Global Endocrine Therapy Drugs (ETDs) Market Price by Company (2021-2026) & (US$/Ton) Table 35. Global Endocrine Therapy Drugs (ETDs) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Endocrine Therapy Drugs (ETDs) Major Company Production Sites and Headquarters Table 37. Global Endocrine Therapy Drugs (ETDs) Company, Product Type & Application Table 38. Global Endocrine Therapy Drugs (ETDs) Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Endocrine Therapy Drugs (ETDs) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Endocrine Therapy Drugs (ETDs) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Endocrine Therapy Drugs (ETDs) Sales by Region (2021-2026) & (Tons) Table 43. Global Endocrine Therapy Drugs (ETDs) Sales Market Share in Volume by Region (2021-2026) Table 44. Global Endocrine Therapy Drugs (ETDs) Sales by Region (2021-2026) & (US$ Million) Table 45. Global Endocrine Therapy Drugs (ETDs) Sales Market Share in Value by Region (2021-2026) Table 46. Global Endocrine Therapy Drugs (ETDs) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 47. Global Endocrine Therapy Drugs (ETDs) Sales by Region (2027-2032) & (Tons) Table 48. Global Endocrine Therapy Drugs (ETDs) Sales Market Share in Volume by Region (2027-2032) Table 49. Global Endocrine Therapy Drugs (ETDs) Sales by Region (2027-2032) & (US$ Million) Table 50. Global Endocrine Therapy Drugs (ETDs) Sales Market Share in Value by Region (2027-2032) Table 51. Global Endocrine Therapy Drugs (ETDs) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 52. Global Endocrine Therapy Drugs (ETDs) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Endocrine Therapy Drugs (ETDs) Sales by Application (2021-2026) & (Tons) Table 54. Global Endocrine Therapy Drugs (ETDs) Sales Market Share in Volume by Application (2021-2026) Table 55. Global Endocrine Therapy Drugs (ETDs) Sales by Application (2021-2026) & (US$ Million) Table 56. Global Endocrine Therapy Drugs (ETDs) Sales Market Share in Value by Application (2021-2026) Table 57. Global Endocrine Therapy Drugs (ETDs) Price by Application (2021-2026) & (US$/Ton) Table 58. Global Endocrine Therapy Drugs (ETDs) Sales by Application (2027-2032) & (Tons) Table 59. Global Endocrine Therapy Drugs (ETDs) Sales Market Share in Volume by Application (2027-2032) Table 60. Global Endocrine Therapy Drugs (ETDs) Sales by Application (2027-2032) & (US$ Million) Table 61. Global Endocrine Therapy Drugs (ETDs) Sales Market Share in Value by Application (2027-2032) Table 62. Global Endocrine Therapy Drugs (ETDs) Price by Application (2027-2032) & (US$/Ton) Table 63. North America Endocrine Therapy Drugs (ETDs) Sales by Application (2021-2026) & (Tons) Table 64. North America Endocrine Therapy Drugs (ETDs) Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Endocrine Therapy Drugs (ETDs) Sales by Application (2021-2026) & (Tons) Table 66. Europe Endocrine Therapy Drugs (ETDs) Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Endocrine Therapy Drugs (ETDs) Sales by Application (2021-2026) & (Tons) Table 68. Asia-Pacific Endocrine Therapy Drugs (ETDs) Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Endocrine Therapy Drugs (ETDs) Sales by Application (2021-2026) & (Tons) Table 70. Latin America Endocrine Therapy Drugs (ETDs) Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Endocrine Therapy Drugs (ETDs) Sales by Application (2021-2026) & (Tons) Table 72. Middle East and Africa Endocrine Therapy Drugs (ETDs) Sales by Application (2021-2026) & (US$ Million) Table 73. Sanofi Company Information Table 74. Sanofi Business Overview Table 75. Sanofi Endocrine Therapy Drugs (ETDs) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Sanofi Endocrine Therapy Drugs (ETDs) Product Portfolio Table 77. Sanofi Recent Development Table 78. Pfizer Company Information Table 79. Pfizer Business Overview Table 80. Pfizer Endocrine Therapy Drugs (ETDs) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. Pfizer Endocrine Therapy Drugs (ETDs) Product Portfolio Table 82. Pfizer Recent Development Table 83. Bayer Company Information Table 84. Bayer Business Overview Table 85. Bayer Endocrine Therapy Drugs (ETDs) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. Bayer Endocrine Therapy Drugs (ETDs) Product Portfolio Table 87. Bayer Recent Development Table 88. AstraZeneca Company Information Table 89. AstraZeneca Business Overview Table 90. AstraZeneca Endocrine Therapy Drugs (ETDs) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. AstraZeneca Endocrine Therapy Drugs (ETDs) Product Portfolio Table 92. AstraZeneca Recent Development Table 93. Tonghua Dongbao Pharmaceutical Company Information Table 94. Tonghua Dongbao Pharmaceutical Business Overview Table 95. Tonghua Dongbao Pharmaceutical Endocrine Therapy Drugs (ETDs) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. Tonghua Dongbao Pharmaceutical Endocrine Therapy Drugs (ETDs) Product Portfolio Table 97. Tonghua Dongbao Pharmaceutical Recent Development Table 98. Novo Nordisk Company Information Table 99. Novo Nordisk Business Overview Table 100. Novo Nordisk Endocrine Therapy Drugs (ETDs) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. Novo Nordisk Endocrine Therapy Drugs (ETDs) Product Portfolio Table 102. Novo Nordisk Recent Development Table 103. MSD Company Information Table 104. MSD Business Overview Table 105. MSD Endocrine Therapy Drugs (ETDs) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 106. MSD Endocrine Therapy Drugs (ETDs) Product Portfolio Table 107. MSD Recent Development Table 108. Huadong Medicine Company Information Table 109. Huadong Medicine Business Overview Table 110. Huadong Medicine Endocrine Therapy Drugs (ETDs) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 111. Huadong Medicine Endocrine Therapy Drugs (ETDs) Product Portfolio Table 112. Huadong Medicine Recent Development Table 113. Generex Biotechnology Company Information Table 114. Generex Biotechnology Business Overview Table 115. Generex Biotechnology Endocrine Therapy Drugs (ETDs) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 116. Generex Biotechnology Endocrine Therapy Drugs (ETDs) Product Portfolio Table 117. Generex Biotechnology Recent Development Table 118. North America Endocrine Therapy Drugs (ETDs) Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 119. North America Endocrine Therapy Drugs (ETDs) Sales by Country (2021-2026) & (Tons) Table 120. North America Endocrine Therapy Drugs (ETDs) Sales Market Share by Country (2021-2026) Table 121. North America Endocrine Therapy Drugs (ETDs) Sales Forecast by Country (2027-2032) & (Tons) Table 122. North America Endocrine Therapy Drugs (ETDs) Sales Market Share Forecast by Country (2027-2032) Table 123. North America Endocrine Therapy Drugs (ETDs) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Endocrine Therapy Drugs (ETDs) Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Endocrine Therapy Drugs (ETDs) Market Share by Country (2021-2026) Table 126. North America Endocrine Therapy Drugs (ETDs) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Endocrine Therapy Drugs (ETDs) Market Share Forecast by Country (2027-2032) Table 128. Europe Endocrine Therapy Drugs (ETDs) Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 129. Europe Endocrine Therapy Drugs (ETDs) Sales by Country (2021-2026) & (Tons) Table 130. Europe Endocrine Therapy Drugs (ETDs) Sales Market Share by Country (2021-2026) Table 131. Europe Endocrine Therapy Drugs (ETDs) Sales Forecast by Country (2027-2032) & (Tons) Table 132. Europe Endocrine Therapy Drugs (ETDs) Sales Market Share Forecast by Country (2027-2032) Table 133. Europe Endocrine Therapy Drugs (ETDs) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Endocrine Therapy Drugs (ETDs) Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Endocrine Therapy Drugs (ETDs) Market Share by Country (2021-2026) Table 136. Europe Endocrine Therapy Drugs (ETDs) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Endocrine Therapy Drugs (ETDs) Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Endocrine Therapy Drugs (ETDs) Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Endocrine Therapy Drugs (ETDs) Sales by Country (2021-2026) & (Tons) Table 140. Asia-Pacific Endocrine Therapy Drugs (ETDs) Sales Market Share by Country (2021-2026) Table 141. Asia-Pacific Endocrine Therapy Drugs (ETDs) Sales Forecast by Country (2027-2032) & (Tons) Table 142. Asia-Pacific Endocrine Therapy Drugs (ETDs) Sales Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Endocrine Therapy Drugs (ETDs) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Endocrine Therapy Drugs (ETDs) Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Endocrine Therapy Drugs (ETDs) Market Share by Country (2021-2026) Table 146. Asia-Pacific Endocrine Therapy Drugs (ETDs) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Endocrine Therapy Drugs (ETDs) Market Share Forecast by Country (2027-2032) Table 148. Latin America Endocrine Therapy Drugs (ETDs) Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 149. Latin America Endocrine Therapy Drugs (ETDs) Sales by Country (2021-2026) & (Tons) Table 150. Latin America Endocrine Therapy Drugs (ETDs) Sales Market Share by Country (2021-2026) Table 151. Latin America Endocrine Therapy Drugs (ETDs) Sales Forecast by Country (2027-2032) & (Tons) Table 152. Latin America Endocrine Therapy Drugs (ETDs) Sales Market Share Forecast by Country (2027-2032) Table 153. Latin America Endocrine Therapy Drugs (ETDs) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Endocrine Therapy Drugs (ETDs) Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Endocrine Therapy Drugs (ETDs) Market Share by Country (2021-2026) Table 156. Latin America Endocrine Therapy Drugs (ETDs) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Endocrine Therapy Drugs (ETDs) Market Share Forecast by Country (2027-2032) Table 158. Middle East and Africa Endocrine Therapy Drugs (ETDs) Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 159. Middle East and Africa Endocrine Therapy Drugs (ETDs) Sales by Country (2021-2026) & (Tons) Table 160. Middle East and Africa Endocrine Therapy Drugs (ETDs) Sales Market Share by Country (2021-2026) Table 161. Middle East and Africa Endocrine Therapy Drugs (ETDs) Sales Forecast by Country (2027-2032) & (Tons) Table 162. Middle East and Africa Endocrine Therapy Drugs (ETDs) Sales Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Endocrine Therapy Drugs (ETDs) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Endocrine Therapy Drugs (ETDs) Market Size by Country (2021-2026) & (US$ Million) Table 165. Middle East and Africa Endocrine Therapy Drugs (ETDs) Market Share by Country (2021-2026) Table 166. Middle East and Africa Endocrine Therapy Drugs (ETDs) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Middle East and Africa Endocrine Therapy Drugs (ETDs) Market Share Forecast by Country (2027-2032) Table 168. Key Raw Materials Table 169. Raw Materials Key Suppliers Table 170. Endocrine Therapy Drugs (ETDs) Distributors List Table 171. Endocrine Therapy Drugs (ETDs) Customers List Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Endocrine Therapy Drugs (ETDs) Image Figure 2. Global Endocrine Therapy Drugs (ETDs) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Endocrine Therapy Drugs (ETDs) Market Size (2021-2032) & (US$ Million) Figure 4. Global Endocrine Therapy Drugs (ETDs) Sales (2021-2032) & (Tons) Figure 5. Antidiabetic Drugs Image Figure 6. Global Antidiabetic Drugs Sales YoY Growth (2021-2032) & (Tons) Figure 7. Anti-osteoporosis Drugs Image Figure 8. Global Anti-osteoporosis Drugs Sales YoY Growth (2021-2032) & (Tons) Figure 9. Contraceptive Image Figure 10. Global Contraceptive Sales YoY Growth (2021-2032) & (Tons) Figure 11. Other Image Figure 12. Global Other Sales YoY Growth (2021-2032) & (Tons) Figure 13. Global Endocrine Therapy Drugs (ETDs) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Endocrine Therapy Drugs (ETDs) Market Share by Type 2025 VS 2032 Figure 15. North America Endocrine Therapy Drugs (ETDs) Sales Market Share in Volume by Type in 2025 Figure 16. North America Endocrine Therapy Drugs (ETDs) Sales Market Share in Value by Type in 2025 Figure 17. Europe Endocrine Therapy Drugs (ETDs) Sales Market Share in Volume by Type in 2025 Figure 18. Europe Endocrine Therapy Drugs (ETDs) Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Endocrine Therapy Drugs (ETDs) Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Endocrine Therapy Drugs (ETDs) Sales Market Share in Value by Type in 2025 Figure 21. Latin America Endocrine Therapy Drugs (ETDs) Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Endocrine Therapy Drugs (ETDs) Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Endocrine Therapy Drugs (ETDs) Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Endocrine Therapy Drugs (ETDs) Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Endocrine Therapy Drugs (ETDs) Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Diabetes Treatment Image Figure 28. Global Diabetes Treatment Sales YoY Growth (2021-2032) & (Tons) Figure 29. Osteoporosis Treatment Image Figure 30. Global Osteoporosis Treatment Sales YoY Growth (2021-2032) & (Tons) Figure 31. Contraception Image Figure 32. Global Contraception Sales YoY Growth (2021-2032) & (Tons) Figure 33. Other Image Figure 34. Global Other Sales YoY Growth (2021-2032) & (Tons) Figure 35. Global Endocrine Therapy Drugs (ETDs) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Endocrine Therapy Drugs (ETDs) Market Share by Application 2025 VS 2032 Figure 37. North America Endocrine Therapy Drugs (ETDs) Sales Market Share in Volume by Application in 2025 Figure 38. North America Endocrine Therapy Drugs (ETDs) Sales Market Share in Value by Application in 2025 Figure 39. Europe Endocrine Therapy Drugs (ETDs) Sales Market Share in Volume by Application in 2025 Figure 40. Europe Endocrine Therapy Drugs (ETDs) Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Endocrine Therapy Drugs (ETDs) Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Endocrine Therapy Drugs (ETDs) Sales Market Share in Value by Application in 2025 Figure 43. Latin America Endocrine Therapy Drugs (ETDs) Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Endocrine Therapy Drugs (ETDs) Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Endocrine Therapy Drugs (ETDs) Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Endocrine Therapy Drugs (ETDs) Sales Market Share in Value by Application in 2025 Figure 47. North America Endocrine Therapy Drugs (ETDs) Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 48. North America Endocrine Therapy Drugs (ETDs) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Endocrine Therapy Drugs (ETDs) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Endocrine Therapy Drugs (ETDs) Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Endocrine Therapy Drugs (ETDs) Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 52. Europe Endocrine Therapy Drugs (ETDs) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Endocrine Therapy Drugs (ETDs) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Endocrine Therapy Drugs (ETDs) Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Endocrine Therapy Drugs (ETDs) Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 56. Asia-Pacific Endocrine Therapy Drugs (ETDs) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Endocrine Therapy Drugs (ETDs) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Endocrine Therapy Drugs (ETDs) Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Endocrine Therapy Drugs (ETDs) Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 60. Latin America Endocrine Therapy Drugs (ETDs) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Endocrine Therapy Drugs (ETDs) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Endocrine Therapy Drugs (ETDs) Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Endocrine Therapy Drugs (ETDs) Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 64. Middle East and Africa Endocrine Therapy Drugs (ETDs) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Endocrine Therapy Drugs (ETDs) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Endocrine Therapy Drugs (ETDs) Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Endocrine Therapy Drugs (ETDs) Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Endocrine Therapy Drugs (ETDs) Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Antidiabetic Drugs
  • Anti-osteoporosis Drugs
  • Contraceptive
  • Other
Applications
  • Diabetes Treatment
  • Osteoporosis Treatment
  • Contraception
  • Other
Companies covered
  • Sanofi
  • Pfizer
  • Bayer
  • AstraZeneca
  • Tonghua Dongbao Pharmaceutical
  • Novo Nordisk
  • MSD
  • Huadong Medicine
  • Generex Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Endocrine Therapy Drugs (ETDs) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Endocrine Therapy Drugs (ETDs) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Endocrine Therapy Drugs (ETDs) Market by Type
  6. 1.3.1 Antidiabetic Drugs
  7. 1.3.2 Anti-osteoporosis Drugs
  8. 1.3.3 Contraceptive
  9. 1.3.4 Other
  10. 1.4 Global Endocrine Therapy Drugs (ETDs) Market Size by Type
  11. 1.4.1 Global Endocrine Therapy Drugs (ETDs) Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Endocrine Therapy Drugs (ETDs) Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Endocrine Therapy Drugs (ETDs) Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Endocrine Therapy Drugs (ETDs) Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Endocrine Therapy Drugs (ETDs) Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Endocrine Therapy Drugs (ETDs) Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Endocrine Therapy Drugs (ETDs) Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Endocrine Therapy Drugs (ETDs) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Endocrine Therapy Drugs (ETDs) Industry Trends
  2. 2.2 Endocrine Therapy Drugs (ETDs) Industry Drivers
  3. 2.3 Endocrine Therapy Drugs (ETDs) Industry Opportunities and Challenges
  4. 2.4 Endocrine Therapy Drugs (ETDs) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Endocrine Therapy Drugs (ETDs) Revenue (2021-2026)
  2. 3.2 Global Top Players by Endocrine Therapy Drugs (ETDs) Sales (2021-2026)
  3. 3.3 Global Top Players by Endocrine Therapy Drugs (ETDs) Price (2021-2026)
  4. 3.4 Global Endocrine Therapy Drugs (ETDs) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Endocrine Therapy Drugs (ETDs) Major Company Production Sites & Headquarters
  6. 3.6 Global Endocrine Therapy Drugs (ETDs) Company, Product Type & Application
  7. 3.7 Global Endocrine Therapy Drugs (ETDs) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Endocrine Therapy Drugs (ETDs) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Endocrine Therapy Drugs (ETDs) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Endocrine Therapy Drugs (ETDs) Tier 1, Tier 2, and Tier 3
4 Endocrine Therapy Drugs (ETDs) Regional Status and Outlook
  1. 4.1 Global Endocrine Therapy Drugs (ETDs) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Endocrine Therapy Drugs (ETDs) Historic Market Size by Region
  3. 4.2.1 Global Endocrine Therapy Drugs (ETDs) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Endocrine Therapy Drugs (ETDs) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Endocrine Therapy Drugs (ETDs) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Endocrine Therapy Drugs (ETDs) Forecasted Market Size by Region
  7. 4.3.1 Global Endocrine Therapy Drugs (ETDs) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Endocrine Therapy Drugs (ETDs) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Endocrine Therapy Drugs (ETDs) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Endocrine Therapy Drugs (ETDs) by Application
  1. 5.1 Endocrine Therapy Drugs (ETDs) Market by Application
  2. 5.1.1 Diabetes Treatment
  3. 5.1.2 Osteoporosis Treatment
  4. 5.1.3 Contraception
  5. 5.1.4 Other
  6. 5.2 Global Endocrine Therapy Drugs (ETDs) Market Size by Application
  7. 5.2.1 Global Endocrine Therapy Drugs (ETDs) Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Endocrine Therapy Drugs (ETDs) Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Endocrine Therapy Drugs (ETDs) Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Endocrine Therapy Drugs (ETDs) Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Endocrine Therapy Drugs (ETDs) Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Endocrine Therapy Drugs (ETDs) Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Endocrine Therapy Drugs (ETDs) Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Endocrine Therapy Drugs (ETDs) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Endocrine Therapy Drugs (ETDs) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Endocrine Therapy Drugs (ETDs) Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer Endocrine Therapy Drugs (ETDs) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer Endocrine Therapy Drugs (ETDs) Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
  13. 6.3 Bayer
  14. 6.3.1 Bayer Company Information
  15. 6.3.2 Bayer Business Overview
  16. 6.3.3 Bayer Endocrine Therapy Drugs (ETDs) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Bayer Endocrine Therapy Drugs (ETDs) Product Portfolio
  18. 6.3.5 Bayer Recent Developments
  19. 6.4 AstraZeneca
  20. 6.4.1 AstraZeneca Company Information
  21. 6.4.2 AstraZeneca Business Overview
  22. 6.4.3 AstraZeneca Endocrine Therapy Drugs (ETDs) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 AstraZeneca Endocrine Therapy Drugs (ETDs) Product Portfolio
  24. 6.4.5 AstraZeneca Recent Developments
  25. 6.5 Tonghua Dongbao Pharmaceutical
  26. 6.5.1 Tonghua Dongbao Pharmaceutical Company Information
  27. 6.5.2 Tonghua Dongbao Pharmaceutical Business Overview
  28. 6.5.3 Tonghua Dongbao Pharmaceutical Endocrine Therapy Drugs (ETDs) Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Tonghua Dongbao Pharmaceutical Endocrine Therapy Drugs (ETDs) Product Portfolio
  30. 6.5.5 Tonghua Dongbao Pharmaceutical Recent Developments
  31. 6.6 Novo Nordisk
  32. 6.6.1 Novo Nordisk Company Information
  33. 6.6.2 Novo Nordisk Business Overview
  34. 6.6.3 Novo Nordisk Endocrine Therapy Drugs (ETDs) Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Novo Nordisk Endocrine Therapy Drugs (ETDs) Product Portfolio
  36. 6.6.5 Novo Nordisk Recent Developments
  37. 6.7 MSD
  38. 6.7.1 MSD Company Information
  39. 6.7.2 MSD Business Overview
  40. 6.7.3 MSD Endocrine Therapy Drugs (ETDs) Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 MSD Endocrine Therapy Drugs (ETDs) Product Portfolio
  42. 6.7.5 MSD Recent Developments
  43. 6.8 Huadong Medicine
  44. 6.8.1 Huadong Medicine Company Information
  45. 6.8.2 Huadong Medicine Business Overview
  46. 6.8.3 Huadong Medicine Endocrine Therapy Drugs (ETDs) Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Huadong Medicine Endocrine Therapy Drugs (ETDs) Product Portfolio
  48. 6.8.5 Huadong Medicine Recent Developments
  49. 6.9 Generex Biotechnology
  50. 6.9.1 Generex Biotechnology Company Information
  51. 6.9.2 Generex Biotechnology Business Overview
  52. 6.9.3 Generex Biotechnology Endocrine Therapy Drugs (ETDs) Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Generex Biotechnology Endocrine Therapy Drugs (ETDs) Product Portfolio
  54. 6.9.5 Generex Biotechnology Recent Developments
7 North America by Country
  1. 7.1 North America Endocrine Therapy Drugs (ETDs) Sales by Country
  2. 7.1.1 North America Endocrine Therapy Drugs (ETDs) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Endocrine Therapy Drugs (ETDs) Sales by Country (2021-2026)
  4. 7.1.3 North America Endocrine Therapy Drugs (ETDs) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Endocrine Therapy Drugs (ETDs) Market Size by Country
  6. 7.2.1 North America Endocrine Therapy Drugs (ETDs) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Endocrine Therapy Drugs (ETDs) Market Size by Country (2021-2026)
  8. 7.2.3 North America Endocrine Therapy Drugs (ETDs) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Endocrine Therapy Drugs (ETDs) Sales by Country
  2. 8.1.1 Europe Endocrine Therapy Drugs (ETDs) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Endocrine Therapy Drugs (ETDs) Sales by Country (2021-2026)
  4. 8.1.3 Europe Endocrine Therapy Drugs (ETDs) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Endocrine Therapy Drugs (ETDs) Market Size by Country
  6. 8.2.1 Europe Endocrine Therapy Drugs (ETDs) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Endocrine Therapy Drugs (ETDs) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Endocrine Therapy Drugs (ETDs) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Endocrine Therapy Drugs (ETDs) Sales by Country
  2. 9.1.1 Asia-Pacific Endocrine Therapy Drugs (ETDs) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Endocrine Therapy Drugs (ETDs) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Endocrine Therapy Drugs (ETDs) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Endocrine Therapy Drugs (ETDs) Market Size by Country
  6. 9.2.1 Asia-Pacific Endocrine Therapy Drugs (ETDs) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Endocrine Therapy Drugs (ETDs) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Endocrine Therapy Drugs (ETDs) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Endocrine Therapy Drugs (ETDs) Sales by Country
  2. 10.1.1 South America Endocrine Therapy Drugs (ETDs) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Endocrine Therapy Drugs (ETDs) Sales by Country (2021-2026)
  4. 10.1.3 South America Endocrine Therapy Drugs (ETDs) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Endocrine Therapy Drugs (ETDs) Market Size by Country
  6. 10.2.1 South America Endocrine Therapy Drugs (ETDs) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Endocrine Therapy Drugs (ETDs) Market Size by Country (2021-2026)
  8. 10.2.3 South America Endocrine Therapy Drugs (ETDs) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Endocrine Therapy Drugs (ETDs) Sales by Country
  2. 11.1.1 Middle East and Africa Endocrine Therapy Drugs (ETDs) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Endocrine Therapy Drugs (ETDs) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Endocrine Therapy Drugs (ETDs) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Endocrine Therapy Drugs (ETDs) Market Size by Country
  6. 11.2.1 Middle East and Africa Endocrine Therapy Drugs (ETDs) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Endocrine Therapy Drugs (ETDs) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Endocrine Therapy Drugs (ETDs) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Endocrine Therapy Drugs (ETDs) Value Chain Analysis
  2. 12.1.1 Endocrine Therapy Drugs (ETDs) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Endocrine Therapy Drugs (ETDs) Production Mode & Process
  7. 12.2 Endocrine Therapy Drugs (ETDs) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Endocrine Therapy Drugs (ETDs) Distributors
  10. 12.2.3 Endocrine Therapy Drugs (ETDs) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst